Marinus (MRNS) Gets Positive FDA Response for Ganaxolone Study

By NASDAQ6 days ago

AD

Shares of Marinus Pharmaceuticals Inc. MRNS rose around 4% after it announced that the FDA issued a positive response stating that the efficacy and safety data from the pivotal phase III Marigold Study on the use of oral ganaxolone in children and young adults with CDKL5 deficien

Continue read on nasdaq.com